HAL vs RCUS · P/E 9.3, $19.05B cap vs rev $258.0M
Halliburton Company (HAL) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the HAL and RCUS stock pages for the full models.
Not investment advice.